The CA19-9 and Sialyl-TRA Antigens Define Separate Subpopulations of Pancreatic Cancer Cells

Abstract Molecular markers to detect subtypes of cancer cells could facilitate more effective treatment. We recently identified a carbohydrate antigen, named sTRA, that is as accurate a serological biomarker of pancreatic cancer as the cancer antigen CA19-9. We hypothesized that the cancer cells pro...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Daniel Barnett, Ying Liu, Katie Partyka, Ying Huang, Huiyuan Tang, Galen Hostetter, Randall E. Brand, Aatur D. Singhi, Richard R. Drake, Brian B. Haab
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/b649fb40325c4fedbdb6aba240fb4df5
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:b649fb40325c4fedbdb6aba240fb4df5
record_format dspace
spelling oai:doaj.org-article:b649fb40325c4fedbdb6aba240fb4df52021-12-02T16:06:36ZThe CA19-9 and Sialyl-TRA Antigens Define Separate Subpopulations of Pancreatic Cancer Cells10.1038/s41598-017-04164-z2045-2322https://doaj.org/article/b649fb40325c4fedbdb6aba240fb4df52017-06-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-04164-zhttps://doaj.org/toc/2045-2322Abstract Molecular markers to detect subtypes of cancer cells could facilitate more effective treatment. We recently identified a carbohydrate antigen, named sTRA, that is as accurate a serological biomarker of pancreatic cancer as the cancer antigen CA19-9. We hypothesized that the cancer cells producing sTRA are a different subpopulation than those producing CA19-9. The sTRA glycan was significantly elevated in tumor tissue relative to adjacent pancreatic tissue in 3 separate tissue microarrays covering 38 patients. The morphologies of the cancer cells varied in association with glycan expression. Cells with dual staining of both markers tended to be in well-to-moderately differentiated glands with nuclear polarization, but exclusive sTRA staining was present in small clusters of cells with poor differentiation and large vacuoles, or in small and ill-defined glands. Patients with higher dual-staining of CA19-9 and sTRA had statistically longer time-to-progression after surgery. Patients with short time-to-progression (<2 years) had either low levels of the dual-stained cells or high levels of single-stained cells, and such patterns differentiated short from long time-to-progression with 90% (27/30) sensitivity and 80% (12/15) specificity. The sTRA and CA19-9 glycans define separate subpopulations of cancer cells and could together have value for classifying subtypes of pancreatic adenocarcinoma.Daniel BarnettYing LiuKatie PartykaYing HuangHuiyuan TangGalen HostetterRandall E. BrandAatur D. SinghiRichard R. DrakeBrian B. HaabNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-13 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Daniel Barnett
Ying Liu
Katie Partyka
Ying Huang
Huiyuan Tang
Galen Hostetter
Randall E. Brand
Aatur D. Singhi
Richard R. Drake
Brian B. Haab
The CA19-9 and Sialyl-TRA Antigens Define Separate Subpopulations of Pancreatic Cancer Cells
description Abstract Molecular markers to detect subtypes of cancer cells could facilitate more effective treatment. We recently identified a carbohydrate antigen, named sTRA, that is as accurate a serological biomarker of pancreatic cancer as the cancer antigen CA19-9. We hypothesized that the cancer cells producing sTRA are a different subpopulation than those producing CA19-9. The sTRA glycan was significantly elevated in tumor tissue relative to adjacent pancreatic tissue in 3 separate tissue microarrays covering 38 patients. The morphologies of the cancer cells varied in association with glycan expression. Cells with dual staining of both markers tended to be in well-to-moderately differentiated glands with nuclear polarization, but exclusive sTRA staining was present in small clusters of cells with poor differentiation and large vacuoles, or in small and ill-defined glands. Patients with higher dual-staining of CA19-9 and sTRA had statistically longer time-to-progression after surgery. Patients with short time-to-progression (<2 years) had either low levels of the dual-stained cells or high levels of single-stained cells, and such patterns differentiated short from long time-to-progression with 90% (27/30) sensitivity and 80% (12/15) specificity. The sTRA and CA19-9 glycans define separate subpopulations of cancer cells and could together have value for classifying subtypes of pancreatic adenocarcinoma.
format article
author Daniel Barnett
Ying Liu
Katie Partyka
Ying Huang
Huiyuan Tang
Galen Hostetter
Randall E. Brand
Aatur D. Singhi
Richard R. Drake
Brian B. Haab
author_facet Daniel Barnett
Ying Liu
Katie Partyka
Ying Huang
Huiyuan Tang
Galen Hostetter
Randall E. Brand
Aatur D. Singhi
Richard R. Drake
Brian B. Haab
author_sort Daniel Barnett
title The CA19-9 and Sialyl-TRA Antigens Define Separate Subpopulations of Pancreatic Cancer Cells
title_short The CA19-9 and Sialyl-TRA Antigens Define Separate Subpopulations of Pancreatic Cancer Cells
title_full The CA19-9 and Sialyl-TRA Antigens Define Separate Subpopulations of Pancreatic Cancer Cells
title_fullStr The CA19-9 and Sialyl-TRA Antigens Define Separate Subpopulations of Pancreatic Cancer Cells
title_full_unstemmed The CA19-9 and Sialyl-TRA Antigens Define Separate Subpopulations of Pancreatic Cancer Cells
title_sort ca19-9 and sialyl-tra antigens define separate subpopulations of pancreatic cancer cells
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/b649fb40325c4fedbdb6aba240fb4df5
work_keys_str_mv AT danielbarnett theca199andsialyltraantigensdefineseparatesubpopulationsofpancreaticcancercells
AT yingliu theca199andsialyltraantigensdefineseparatesubpopulationsofpancreaticcancercells
AT katiepartyka theca199andsialyltraantigensdefineseparatesubpopulationsofpancreaticcancercells
AT yinghuang theca199andsialyltraantigensdefineseparatesubpopulationsofpancreaticcancercells
AT huiyuantang theca199andsialyltraantigensdefineseparatesubpopulationsofpancreaticcancercells
AT galenhostetter theca199andsialyltraantigensdefineseparatesubpopulationsofpancreaticcancercells
AT randallebrand theca199andsialyltraantigensdefineseparatesubpopulationsofpancreaticcancercells
AT aaturdsinghi theca199andsialyltraantigensdefineseparatesubpopulationsofpancreaticcancercells
AT richardrdrake theca199andsialyltraantigensdefineseparatesubpopulationsofpancreaticcancercells
AT brianbhaab theca199andsialyltraantigensdefineseparatesubpopulationsofpancreaticcancercells
AT danielbarnett ca199andsialyltraantigensdefineseparatesubpopulationsofpancreaticcancercells
AT yingliu ca199andsialyltraantigensdefineseparatesubpopulationsofpancreaticcancercells
AT katiepartyka ca199andsialyltraantigensdefineseparatesubpopulationsofpancreaticcancercells
AT yinghuang ca199andsialyltraantigensdefineseparatesubpopulationsofpancreaticcancercells
AT huiyuantang ca199andsialyltraantigensdefineseparatesubpopulationsofpancreaticcancercells
AT galenhostetter ca199andsialyltraantigensdefineseparatesubpopulationsofpancreaticcancercells
AT randallebrand ca199andsialyltraantigensdefineseparatesubpopulationsofpancreaticcancercells
AT aaturdsinghi ca199andsialyltraantigensdefineseparatesubpopulationsofpancreaticcancercells
AT richardrdrake ca199andsialyltraantigensdefineseparatesubpopulationsofpancreaticcancercells
AT brianbhaab ca199andsialyltraantigensdefineseparatesubpopulationsofpancreaticcancercells
_version_ 1718384984877694976